FBIOX
Fidelity Select Biotechnology Portfolio
1W: -1.5%
1M: -7.6%
3M: -5.8%
YTD: -2.9%
1Y: +23.1%
3Y: +60.4%
5Y: +15.2%
$24.98
+0.74 (+3.05%)
ETF-Level Metrics
AUM$5.5B
Holdings147
Top 10 Wt58.4%
Beta0.98
% Profitable14%
Coverage89%
Portfolio Valuation
P/E53.6
P/B39.3
P/S6.0
EV/EBITDA15.3
P/FCF21.5
PEG-4.36
Profitability & Returns
Gross Margin83.2%
Net Margin10.2%
ROE75.7%
ROA4.6%
ROIC17.7%
Div Yield0.92%
Leverage & Liquidity
Debt/Equity7.36
Debt/Assets0.51
Net Debt/EBITDA2.1x
Interest Cov3.8x
Current Ratio0.90
Quick Ratio0.75
Growth (YoY)
Revenue+48.2%
Net Income+41.0%
EPS+46.2%
FCF+29.4%
EBITDA+45.7%
Rev CAGR 3Y+50.7%
Quality Scores
Piotroski F4.8
Altman Z12.83
IS Quality62.5
IS Overall59.9
IS Value37.0
Median P/E-7.4
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 146 | 97.4% | -8.3 |
| Other | 30 | 6.8% | — |
| Consumer Defensive | 1 | 0.8% | 50.8 |
Smart Money Overlap
2 holdings with signals
Showing 50 of 177 holdings
· Page 1 of 4
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | ABBVIE INC | ABBV | 16.67% | $705.0M | 3,350,739 | 87.3 | $366.3B | Healthcare |
| 2 | AMGEN INC | AMGN | 8.21% | $347.1M | 1,206,501 | 24.7 | $190.8B | Healthcare |
| 3 | GILEAD SCIENCES INC | GILD.SW | 8.05% | $340.5M | 3,013,711 | — | $142.5B | Healthcare |
| 4 | ALNYLAM PHARMACEUTICALS INC | ALNY | 6.92% | $292.5M | 655,003 | 138.5 | $43.6B | Healthcare |
| 5 | KRYSTAL BIOTECH INC | KRYS | 6.48% | $274.0M | 1,855,422 | 36.0 | $7.5B | Healthcare |
| 6 | Fidelity Revere Street Trust Private | — | 5.00% | $211.3M | 211,241,812 | — | — | — |
| 7 | INSMED INC | INSM | 3.24% | $137.1M | 1,007,619 | -24.8 | $32.0B | Healthcare |
| 8 | ARGENX SE | ARGX | 2.78% | $117.5M | 165,004 | 37.8 | $43.1B | Healthcare |
| 9 | ASCENDIS PHARMA A/S | ASND | 2.68% | $113.2M | 582,501 | -51.5 | $13.6B | Healthcare |
| 10 | UCB SA | UCB.BR | 2.09% | $75.5M | 377,874 | 31.0 | $48.3B | Healthcare |
| 11 | NATERA INC | NTRA | 1.32% | $55.8M | 331,532 | -129.6 | $28.0B | Healthcare |
| 12 | SCHOLAR ROCK HOLDING CORP | SRRK | 1.26% | $53.3M | 1,632,599 | -13.8 | $5.2B | Healthcare |
| 13 | ABIVAX SA | ABVX | 1.22% | $51.5M | 636,000 | -31.1 | $7.3B | Healthcare |
| 14 | DISC MEDICINE INC | IRON | 1.10% | $46.7M | 783,188 | -10.4 | $2.4B | Healthcare |
| 15 | MERUS NV | MRUS | 1.10% | $46.3M | 703,554 | -19.5 | $6.8B | Healthcare |
| 16 | CORCEPT THERAPEUTICS INC | CORT | 1.07% | $45.2M | 648,746 | 42.4 | $4.3B | Healthcare |
| 17 | REGENERON PHARMACEUTICALS INC | REGN | 1.06% | $44.9M | 77,396 | 17.1 | $77.9B | Healthcare |
| 18 | ARRIVENT BIOPHARMA INC | AVBP | 1.06% | $44.9M | 2,346,517 | -5.3 | $1.0B | Healthcare |
| 19 | ZEALAND PHARMA A/S | ZLDPF | 1.06% | $285.7M | 653,130 | 3.1 | $3.1B | Healthcare |
| 20 | CENTESSA PHARMACEUTICALS PLC | CNTA | 1.04% | $43.9M | 2,614,494 | -15.6 | $3.8B | Healthcare |
| 21 | GALDERMA GROUP AG | GALD.SW | 0.85% | $28.7M | 205,570 | 50.8 | $34.8B | Consumer Defensive |
| 22 | SUMMIT THERAPEUTICS INC | SMMT | 0.82% | $34.8M | 1,468,678 | -12.4 | $13.4B | Healthcare |
| 23 | ARCELLX INC | ACLX | 0.81% | $34.5M | 496,600 | -28.2 | $6.7B | Healthcare |
| 24 | AVIDITY BIOSCIENCES INC | RNAM | 0.80% | $33.9M | 727,307 | — | $11.3B | Healthcare |
| 25 | BRIDGEBIO PHARMA INC | BBIO | 0.77% | $32.8M | 632,804 | -19.4 | $13.9B | Healthcare |
| 26 | CANDEL THERAPEUTICS INC | CADL | 0.76% | $32.1M | 5,544,979 | -7.2 | $274M | Healthcare |
| 27 | STOKE THERAPEUTICS INC | STOK | 0.73% | $30.9M | 1,565,839 | -286.6 | $2.0B | Healthcare |
| 28 | BIO AB HOLDINGS LLC Private | — | 0.69% | $29.2M | 1,954,526 | — | — | — |
| 29 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 0.68% | $28.9M | 518,858 | -5.1 | $1.3B | Healthcare |
| 30 | CRINETICS PHARMACEUTICALS INC | CRNX | 0.67% | $28.5M | 919,404 | -7.3 | $3.8B | Healthcare |
| 31 | BIOHAVEN LTD | BHVN | 0.64% | $27.0M | 1,757,096 | -1.4 | $912M | Healthcare |
| 32 | METSERA INC | MTSR | 0.64% | $26.9M | 761,547 | -23.6 | $7.4B | Healthcare |
| 33 | PROTAGONIST THERAPEUTICS INC | PTGX | 0.60% | $25.3M | 429,113 | -51.0 | $6.7B | Healthcare |
| 34 | DYNE THERAPEUTICS INC | DYN | 0.54% | $22.8M | 1,689,544 | -5.5 | $3.1B | Healthcare |
| 35 | MADRIGAL PHARMACEUTICALS INC | MDGL | 0.53% | $22.3M | 50,895 | -35.9 | $10.6B | Healthcare |
| 36 | ULTRAGENYX PHARMACEUTICAL INC | RARE | 0.52% | $21.8M | 727,789 | -3.4 | $1.9B | Healthcare |
| 37 | IONIS PHARMACEUTICALS INC | 0JDI.L | 0.50% | $21.4M | 500,777 | -30.9 | $11.7B | Healthcare |
| 38 | TG THERAPEUTICS INC | TGTX | 0.50% | $21.0M | 714,578 | 10.2 | $5.1B | Healthcare |
| 39 | NUVALENT INC | NUVL | 0.49% | $20.6M | 268,899 | -17.3 | $7.2B | Healthcare |
| 40 | CYTOKINETICS INC | CYTK | 0.45% | $19.1M | 540,575 | -9.7 | $7.7B | Healthcare |
| 41 | COGENT BIOSCIENCES INC | COGT | 0.45% | $18.9M | 1,566,594 | -7.5 | $5.9B | Healthcare |
| 42 | TREVI THERAPEUTICS INC | TRVI | 0.45% | $18.8M | 2,593,763 | -38.9 | $1.5B | Healthcare |
| 43 | VAXCYTE INC | PCVX | 0.44% | $18.5M | 599,955 | -9.9 | $8.0B | Healthcare |
| 44 | EXELIXIS INC | EXEL | 0.42% | $17.6M | 471,554 | 14.8 | $11.5B | Healthcare |
| 45 | NUVATION BIO INC | NUVB | 0.41% | $17.3M | 5,827,833 | -7.4 | $1.5B | Healthcare |
| 46 | VIRIDIAN THERAPEUTICS INC | VRDN | 0.40% | $16.9M | 917,404 | -7.0 | $2.4B | Healthcare |
| 47 | NEWAMSTERDAM PHARMA COMPANY NV | NAMS | 0.39% | $16.5M | 687,500 | -17.4 | $3.6B | Healthcare |
| 48 | MODERNA INC | MRNA | 0.38% | $16.2M | 674,122 | -7.4 | $21.1B | Healthcare |
| 49 | RHYTHM PHARMACEUTICALS INC | RYTM | 0.38% | $16.2M | 157,003 | -28.8 | $5.8B | Healthcare |
| 50 | XENON PHARMACEUTICALS INC | XENE | 0.38% | $15.9M | 411,764 | -12.7 | $4.6B | Healthcare |